Citation Impact
Citing Papers
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
The time course of the immune response to experimental coronavirus infection of man
1990
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
1999 Standout
Psychological Stress and Susceptibility to the Common Cold
1991 Standout
The protein Id: A negative regulator of helix-loop-helix DNA binding proteins
1990 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
Dendritic cells: versatile controllers of the immune system
2007 StandoutNobel
Evidence of Apoptosis in Arrhythmogenic Right Ventricular Dysplasia
1996 Standout
Structural basis of immunosuppression by the therapeutic antibody daclizumab
2010
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
1994 StandoutNobel
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Myasthenia Gravis
1994 Standout
Mechanism and Biological Significance of CD4‐mediated Cytotoxicity
1995
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
2006
Lethal effect of the anti-Fas antibody in mice
1993 StandoutNature
Polymeric micelles for drug targeting
2007
P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.
1993
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
1998 Standout
Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells
1996
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
Determination of humanized anti-Tac in human serum by a sandwich enzyme linked immunosorbent assay
1995
A PHASE I TRIAL OF HUMANIZED ANTI-INTERLEUKIN 2 RECEPTOR ANTIBODY IN RENAL TRANSPLANTATION1
1997
Autoimmune disease. a problem of defective apoptosis
1994
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Role of Hypoxia-inducible Factor-1 in Transcriptional Activation of Ceruloplasmin by Iron Deficiency
2000
The Fas Death Factor
1995 StandoutScience
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Immunotherapy: past, present and future
2003
HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells
2007 StandoutNobel
The Multichain Interleukin-2 Receptor: A Target for Immunotherapy
1992
Avoidance of Cyclosporine in Renal Transplantation
2000
Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards
1987 StandoutNobel
Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen
2000 Standout
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia
1990
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
In-cell PCR from mRNA: amplifying and linking the rearranged immunoglobulin heavy and light chain V-genes within single cells
1992 StandoutNobel
REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1
1999
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.
1977 Standout
Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis
1980
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Carbon quantum dots and their applications
2014 Standout
Proteasome regulation of activation-induced T cell death
1997 StandoutNobel
Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology
2005 Standout
Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma.
1982
Primary Biliary Cirrhosis
1987 Standout
The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif.
1989
Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas
1980
Expansion of natural killer cells but not T cells in human interleukin 2/interleukin 2 receptor (Tac) transgenic mice.
1989 StandoutNobel
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma
2012 StandoutNobel
Isolation of a New Human Retrovirus from West African Patients with AIDS
1986 StandoutScienceNobel
Burkitt's Lymphoma
1981
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes Implications for Immunotherapy
2001
The Human Interleukin-2 Receptor
1986
Molecular cloning of lymphadenopathy-associated virus
1984 StandoutNatureNobel
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
2001 StandoutNobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Drug Discovery: A Historical Perspective
2000 StandoutScience
Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag
2009 StandoutNobel
Tumor immunity against adult T‐cell leukemia
2005
A humanized antibody that binds to the interleukin 2 receptor.
1989
Unrelated donor marrow transplantation in children
1995
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma
1980 Standout
The interleukin-2 receptor.
1991
Expression of the functional soluble form of human fas ligand in activated lymphocytes.
1995
Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis
1994
Interleukin 2-diphtheria toxin fusion protein can abolish cell-mediated immunity in vivo.
1988
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection
1985
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
A Cell Culture Model for T Lymphocyte Clonal Anergy
1990 StandoutScience
The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant Lymphocytes
1986 Science
Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and Expansion
1997 StandoutNobel
VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes.
1989 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias.
1994
Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.
1991
Contrasting Roles of IL-2 and IL-15 in the Life and Death of Lymphocytes
2001
Regulation of T-cell receptor gene expression in human T-cell development.
1985 StandoutNobel
Role of A2a Extracellular Adenosine Receptor-Mediated Signaling in Adenosine-Mediated Inhibition of T-Cell Activation and Expansion
1997 StandoutNobel
Phenotypic heterogeneity and cellular origins of T cell malignancies
1981
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Transmission Dynamics and Control of Severe Acute Respiratory Syndrome
2003 StandoutScience
Monoclonal Antibodies in Diagnosis and Therapy
1991 Science
Interleukin-2: Inception, Impact, and Implications
1988 StandoutScience
Works of Waldmann Ta being referenced
Early experience with anti-Tac in clinical renal transplantation.
1989
Synthesis of plasma proteins by hepatectomized dogs
1966
CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells
1989
The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia
1993
Evolution of a lymphoma with helper T cell characteristics in Sezary syndrome
1978
Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia
1989
Monoclonal anti-IL-2 receptor antibody in primate renal transplantation.
1987
Adult T cell leukemia: a potential target for ricin A chain immunotoxins
1985
Prolongation of primate renal allografts with anti-Tac monoclonal antibody.
1988
Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2
1988
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor
1994
Suppressor cells in the regulation of the immune response.
1977
Changes in IgA and IgG concentrations in nasal secretions prior to the appearance of antibody during viral respiratory infection in man.
1970
APO-1-induced apoptosis of leukemia cells from patients with adult T- cell leukemia
1993
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor
1994
Immunoregulatory functions of cultured human T lymphocytes.
1980
Neoplasms of immunoregulatory cells.
1979